GGrantIndex
Sort

15,440 grants matching organoids

Targeted degradation of KRAS oncoproteins triggers antitumor immunity and abolishes lung tumor

$189,756
Hua Zhang · University Of Pittsburgh At Pittsburgh · K22 · FY2025 · CA

Targeted degradation of KRAS oncoproteins triggers antitumor immunity and abolishes lung tumor

$189,756
Hua Zhang · University Of Pittsburgh At Pittsburgh · K22 · FY2024 · CA

(PQ11) Dietary strategies to enhance FOLFOX cancer therapies

$189,744
Daniel W Rosenberg · University Of Connecticut Sch Of Med/Dnt · R21 · FY2018 · CA

The Neuroprotective Effects of Sulforaphane in VPA-Induced Models of Autism

$189,688
Karen A Litwa · East Carolina University · R21 · FY2023 · AT

Rejuvenate aged adaptive immunity with bioengineered thymus organoids

$189,470
Yong Fan · Allegheny-Singer Research Institute · R21 · FY2017 · AI

Targeted disruption of the YAP/TAZ/TEAD axis in pancreatic cancer

$189,432
Behnam Nabet · Fred Hutchinson Cancer Center · K22 · FY2022 · CA

Targeted disruption of the YAP/TAZ/TEAD axis in pancreatic cancer

$189,432
Behnam Nabet · Fred Hutchinson Cancer Center · K22 · FY2023 · CA

NEURAL CELL ENGINEERING AND IMAGING CORE

$189,354
Kostantin Dobrenis · Albert Einstein College Of Medicine · P50 · FY2023 · HD

NEURAL CELL ENGINEERING AND IMAGING CORE

$189,354
Kostantin Dobrenis · Albert Einstein College Of Medicine · P50 · FY2022 · HD

NEURAL CELL ENGINEERING AND IMAGING CORE

$189,354
Kostantin Dobrenis · Albert Einstein College Of Medicine · P50 · FY2025 · HD

NEURAL CELL ENGINEERING AND IMAGING CORE

$189,354
Kostantin Dobrenis · Albert Einstein College Of Medicine · P50 · FY2024 · HD

Liposome-based mRNA cancer immunotherapy targeting ion channels

$189,338
Laura Conforti · University Of Cincinnati · R21 · FY2023 · CA

Engineering the Organizer

$189,270
Lance A Davidson · University Of Pittsburgh At Pittsburgh · R21 · FY2022 · HD

Core-based scientist specializing in high throughput screening for early drug discovery, target identification and systems biology analysis of cancer

$189,165
Meng Wu · Ohio State University · R50 · FY2023 · CA

Core-based scientist specializing in high throughput screening for early drug discovery, target identification and systems biology analysis of cancer

$189,165
Meng Wu · Ohio State University · R50 · FY2022 · CA

Optical Microscopy Core

$189,159
Mark A. Mc Niven · Mayo Clinic Rochester · P30 · FY2019 · DK

Optical Microscopy Core

$189,159
Mark A. Mc Niven · Mayo Clinic Rochester · P30 · FY2022 · DK

Optical Microscopy Core

$189,159
Mark A. Mc Niven · Mayo Clinic Rochester · P30 · FY2021 · DK

Optical Microscopy Core

$189,159
Mark A. Mc Niven · Mayo Clinic Rochester · P30 · FY2023 · DK

Bile acids and insulin sensitivity

$189,111
Rebecca Anne Haeusler · Columbia University Health Sciences · R01 · FY2020 · DK

Preclinical Models Core

$189,108
Zhaolan Zhou · Children'S Hosp Of Philadelphia · P50 · FY2021 · HD

Discovery of Marine Natural Products Effective against the AIDS associated pathogen Cryptosporidium

$189,063
Roberta M O'Connor · Washington State University · R21 · FY2019 · AI

Clinical Research & Study Design Core

$189,002
Fasiha Kanwal · Baylor College Of Medicine · P30 · FY2024 · DK

Clinical Research & Study Design Core

$189,002
Fasiha Kanwal · Baylor College Of Medicine · P30 · FY2025 · DK

Functional Molecular Investigation of Inflammatory Bowel Disease (IBD) Risk Variants

$189,000
Alexander Marson · J. David Gladstone Institutes · R01 · FY2021 · DK